Personal Home Page

http://www.mailmanschool.org/sphdir/pers.asp?ID=673

Articles in Scholarly Journals [Incomplete List]

1. Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; Results from the European prospective investigation into cancer and nutrition
   International Journal of Cancer, vol. 120, no. 12, pp. 2656–2664, 2007
2. Physical activity and risk of endometrial cancer: The European prospective investigation into cancer and nutrition
   International Journal of Cancer, vol. 121, no. 2, pp. 347–355, 2007
3. Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition
   International Journal of Cancer, vol. 121, no. 2, pp. 368–376, 2007
4. Fruit and vegetable consumption and lung cancer risk: Updated information from the European Prospective Investigation into Cancer and Nutrition (EPIC)
   International Journal of Cancer, vol. 121, no. 5, pp. 1103–1114, 2007
5. Serum androgens and prostate cancer among 643 cases and 643 controls in the European Prospective Investigation into Cancer and Nutrition
   International Journal of Cancer, vol. 121, no. 6, pp. 1331–1338, 2007
6. Response to the letter to the editor
   International Journal of Cancer, vol. 120, no. 8, pp. 1827–1827, 2007
7. Alcohol intake and breast cancer risk: the European Prospective Investigation into Cancer and Nutrition (EPIC)
   Cancer Causes & Control, vol. 18, no. 4, pp. 361–373, 2007
8. Anthropometric factors and risk of endometrial cancer: the European prospective investigation into cancer and nutrition
   Cancer Causes & Control, vol. 18, no. 4, pp. 399–413, 2007
9. Fruit and vegetable consumption and lymphoma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC)
   Cancer Causes & Control, vol. 18, no. 5, pp. 537–549, 2007
10. Alcohol consumption and risk of leukemia: A multicenter case–control study
    Leukemia Research, vol. 31, no. 3, pp. 379–386, 2007
11. Circulating free DNA in plasma or serum as biomarker of carcinogenesis: Practical aspects and biological significance
    Mutation Research/Reviews in Mutation Research, vol. 635, no. 2-3, pp. 105–117, 2007
12. The challenge of low levels of exposure
    Preventive Medicine, vol. 44, no. 2, pp. 107–108, 2007
13. A dietary pattern rich in olive oil and raw vegetables is associated with lower mortality in Italian elderly subjects
    British Journal of Nutrition, vol. 98, no. 02, p. 406, 2007
14. Expression of DNA repair and metabolic genes in response to a flavonoid-rich diet
    British Journal of Nutrition, vol. 98, no. 03, p. 525, 2007
15. Lactase Persistence and Bitter Taste Response: Instrumental Variables and Mendelian Randomization in Epidemiologic Studies of Dietary Factors and Cancer Risk
    American Journal of Epidemiology, vol. 166, no. 5, pp. 576–581, 2007
16. Intake of fruits and vegetables and polymorphisms in DNA repair genes in bladder cancer
    Mutagenesis, vol. 22, no. 4, pp. 281–285, 2007
17. The Emergence of Networks in Human Genome Epidemiology
    Epidemiology, vol. 18, no. 1, pp. 1–8, 2007
18. Exposure to the Tobacco Smoke Constituent 4-Aminobiphenyl Induces Chromosomal Instability in Human Cancer Cells
    Cancer Research, vol. 67, no. 15, pp. 7088–7094, 2007
19. Haplotype-Based Analysis of Common Variation in the Acetyl-CoA Carboxylase   Gene and Breast Cancer Risk: A Case-Control Study Nested within the European Prospective Investigation into Cancer and Nutrition
    Cancer Epidemiology Biomarkers & Prevention, vol. 16, no. 3, pp. 409–415, 2007
20. Endogenous Androgens and Risk of Epithelial Ovarian Cancer: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC)
    Cancer Epidemiology Biomarkers & Prevention, vol. 16, no. 1, pp. 23–29, 2007
21. No Association of Consumption of Animal Foods with Risk of Ovarian Cancer
    Cancer Epidemiology Biomarkers & Prevention, vol. 16, no. 4, pp. 852–855, 2007
22. Exposure to Solvents and Risk of Non-Hodgkin Lymphoma: Clues on Putative Mechanisms
    Cancer Epidemiology Biomarkers & Prevention, vol. 16, no. 3, pp. 381–384, 2007
23. Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph)
    Blood, vol. 109, no. 8, pp. 3479–3488, 2007
24. Environmental Health, vol. 6, no. 1, p. 7, 2007
25. Proteome characterization of a human urothelial cell line resistant to the bladder carcinogen 4-aminobiphenyl
    Proteome Science, vol. 5, no. 1, p. 6, 2007
26. Physical Activity and Breast Cancer Risk: The European Prospective Investigation into Cancer and Nutrition
    Cancer Epidemiology Biomarkers & Prevention, vol. 16, no. 1, pp. 36–42, 2007
27. Physical Activity and Risk of Colon and Rectal Cancers: The European Prospective Investigation into Cancer and Nutrition
    Cancer Epidemiology Biomarkers & Prevention, vol. 15, no. 12, pp. 2398–2407, 2006
28. Anthropometry, Physical Activity, and the Risk of Pancreatic Cancer in the European Prospective Investigation into Cancer and Nutrition
    Cancer Epidemiology Biomarkers & Prevention, vol. 15, no. 5, pp. 879–885, 2006
29. Cancer and Pesticides: An Overview and Some Results of the Italian Multicenter Case-Control Study on Hematolymphopoietic Malignancies
    Annals of the New York Academy of Sciences, vol. 1076, no. 1, pp. 366–377, 2006
30. Misuse of Genetic Data in Environmental Epidemiology
    Annals of the New York Academy of Sciences, vol. 1076, no. 1, pp. 163–167, 2006
31. Environment, Population, and Biology: a short history of modern epidemiology
    Perspectives in Biology and Medicine, vol. 49, no. 3, pp. 357–368, 2006
32. Environmental Health: A Global Access Science Source, vol. 5, no. 1, p. 21, 2006
33. Occupational Exposure to Solvents and the Risk of Lymphomas
    Epidemiology, vol. 17, no. 5, pp. 552–561, 2006
34. TP53 and KRAS2 Mutations in Plasma DNA of Healthy Subjects and Subsequent Cancer Occurrence: A Prospective Study
    Cancer Research, vol. 66, no. 13, pp. 6871–6876, 2006
35. Body Size and Risk of Colon and Rectal Cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC)
    CancerSpectrum Knowledge Environment, vol. 98, no. 13, pp. 920–931, 2006
36. Randomized controlled trial: effects of diet on DNA damage in heavy smokers
    Mutagenesis, vol. 21, no. 3, pp. 179–183, 2006
37. The population dynamics of cancer: a Darwinian perspective
    International Journal of Epidemiology, vol. 35, no. 5, pp. 1151–1159, 2006
38. Socioeconomic position and the risk of gastric and oesophageal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST)
    International Journal of Epidemiology, vol. 36, no. 1, pp. 66–76, 2006
39. Commentary: First steps in molecular epidemiology: Lower et al. 1979
    International Journal of Epidemiology, vol. 36, no. 1, pp. 20–22, 2006
40. XRCC3 and XPD/ERCC2 Single Nucleotide Polymorphisms and the Risk of Cancer: A HuGE Review
    American Journal of Epidemiology, vol. 164, no. 4, pp. 297–302, 2006
41. Ethanol Intake and Risk of Lung Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)
    American Journal of Epidemiology, vol. 164, no. 11, pp. 1103–1114, 2006
42. Analysis of epidemiological cohort data on smoking effects and lung cancer with a multi-stage cancer model
    Carcinogenesis, vol. 27, no. 7, pp. 1432–1444, 2006
43. Multi-factor dimensionality reduction applied to a large prospective investigation on gene-gene and gene-environment interactions
    Carcinogenesis, vol. 28, no. 2, pp. 414–422, 2006
44. Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study
    British Journal of Cancer, vol. 94, no. 2, Article ID 6602936, 8 pages, 2006
45. Associations between dietary pattern and lifestyle, anthropometry and other health indicators in the elderly participants of the EPIC-Italy cohort
    Nutrition, Metabolism and Cardiovascular Diseases, vol. 16, no. 3, pp. 186–201, 2006
46. A Pooled Analysis of Bladder Cancer Case–Control Studies Evaluating Smoking in Men and Women
    Cancer Causes & Control, vol. 17, no. 1, pp. 71–79, 2006
47. CagA+Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study
    International Journal of Cancer, vol. 120, no. 4, pp. 859–867, 2006
48. Anthropometric measures, endogenous sex steroids and breast cancer risk in postmenopausal women: A study within the EPIC cohort
    International Journal of Cancer, vol. 118, no. 11, pp. 2832–2839, 2006
49. Fruits and vegetables and renal cell carcinoma: Findings from the European prospective investigation into cancer and nutrition (EPIC)
    International Journal of Cancer, vol. 118, no. 12, pp. 3133–3139, 2006
50. Air pollution and risk of lung cancer in a prospective study in Europe
    International Journal of Cancer, vol. 119, no. 1, pp. 169–174, 2006
51. Physical activity and lung cancer risk in the European Prospective Investigation into Cancer and Nutrition Cohort
    International Journal of Cancer, vol. 119, no. 10, pp. 2389–2397, 2006
52. Tobacco smoke and bladder cancer—in the European prospective investigation into cancer and nutrition
    International Journal of Cancer, vol. 119, no. 10, pp. 2412–2416, 2006
53. Immunotoxic effects of chemicals: A matrix for occupational and environmental epidemiological studies
    American Journal of Industrial Medicine, vol. 49, no. 12, pp. 1046–1055, 2006
54. Consumption of Vegetables and Fruits and Risk of Breast Cancer
    JAMA: The Journal of the American Medical Association, vol. 293, no. 2, pp. 183–193, 2005
55. Body size and risk of renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC)
    International Journal of Cancer, vol. 118, no. 3, pp. 728–738, 2005
56. C-peptide, IGF-I, sex-steroid hormones and adiposity: a cross-sectional study in healthy women within the European Prospective Investigation into Cancer and Nutrition (EPIC)
    Cancer Causes & Control, vol. 16, no. 5, pp. 561–572, 2005
57. Scientific basis for the Precautionary Principle
    Toxicology and Applied Pharmacology, vol. 207, no. 2, pp. 658–662, 2005
58. Methodology of laboratory measurements in prospective studies on gene–environment interactions: The experience of GenAir
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 574, no. 1-2, pp. 92–104, 2005
59. Plasma carotenoids as biomarkers of intake of fruits and vegetables: individual-level correlations in the European Prospective Investigation into Cancer and Nutrition (EPIC)
    European Journal of Clinical Nutrition, vol. 59, no. 12, Article ID 1602252, 9 pages, 2005
60. Air pollution and cancer: biomarker studies in human populations
    Carcinogenesis, vol. 26, no. 11, pp. 1846–1855, 2005
61. DNA repair polymorphisms and cancer risk in non-smokers in a cohort study
    Carcinogenesis, vol. 27, no. 5, pp. 997–1007, 2005
62. A Network of Investigator Networks in Human Genome Epidemiology
    American Journal of Epidemiology, vol. 162, no. 4, pp. 302–304, 2005
63. Measuring DNA Repair Capacity: Small Steps
    CancerSpectrum Knowledge Environment, vol. 97, no. 2, pp. 84–85, 2005
64. Gene-Environment Interactions: How Many False Positives?
    CancerSpectrum Knowledge Environment, vol. 97, no. 8, pp. 550–551, 2005
65. Serum Sex Steroids in Premenopausal Women and Breast Cancer Risk Within the European Prospective Investigation into Cancer and Nutrition (EPIC)
    CancerSpectrum Knowledge Environment, vol. 97, no. 10, pp. 755–765, 2005
66. Meat, Fish, and Colorectal Cancer Risk: The European Prospective Investigation into Cancer and Nutrition
    CancerSpectrum Knowledge Environment, vol. 97, no. 12, pp. 906–916, 2005
67. Randomized controlled trial: effect of nutritional counselling in general practice
    International Journal of Epidemiology, vol. 35, no. 2, pp. 409–415, 2005
68. Genetic screening and occupational and environmental exposures
    Occupational and Environmental Medicine, vol. 62, no. 9, pp. 657–662, 2005
69. Environmental tobacco smoke and risk of respiratory cancer and chronic obstructive pulmonary disease in former smokers and never smokers in the EPIC prospective study
    BMJ, vol. 330, no. 7486, pp. 277–0, 2005
70. Design Options for Molecular Epidemiology Research within Cohort Studies
    Cancer Epidemiology Biomarkers & Prevention, vol. 14, no. 8, pp. 1899–1907, 2005
71. Genetic Variation in the Growth Hormone Synthesis Pathway in Relation to Circulating Insulin-Like Growth Factor-I, Insulin-Like Growth Factor Binding Protein-3, and Breast Cancer Risk: Results from the European Prospective Investigation into Cancer and Nutrition Study
    Cancer Epidemiology Biomarkers & Prevention, vol. 14, no. 10, pp. 2316–2325, 2005
72. Is the Association with Fiber from Foods in Colorectal Cancer Confounded by Folate Intake?
    Cancer Epidemiology Biomarkers & Prevention, vol. 14, no. 6, pp. 1552–1556, 2005
73. 4-Aminobiphenyl-Hemoglobin Adducts and Risk of Smoking-Related Disease in Never Smokers and Former Smokers in the European Prospective Investigation into Cancer and Nutrition Prospective Study
    Cancer Epidemiology Biomarkers & Prevention, vol. 14, no. 9, pp. 2118–2124, 2005
74. Fruit and Vegetable Consumption and Risk of Epithelial Ovarian Cancer: The European Prospective Investigation into Cancer and Nutrition
    Cancer Epidemiology Biomarkers & Prevention, vol. 14, no. 11, pp. 2531–2535, 2005
75. Polymorphisms/Haplotypes in DNA Repair Genes and Smoking: A Bladder Cancer Case-Control Study
    Cancer Epidemiology Biomarkers & Prevention, vol. 14, no. 11, pp. 2569–2578, 2005
76. Personal Use of Hair Dyes and Hematolymphopoietic Malignancies
    Archives of Environmental Health: An International Journal, vol. 60, no. 5, pp. 249–256, 2005
77. Tobacco and Cancer: Recent Epidemiological Evidence
    CancerSpectrum Knowledge Environment, vol. 96, no. 2, pp. 99–106, 2004
78. Introduction to the symposium: what evidence based medicine is and what it is not
    Journal of Medical Ethics, vol. 30, no. 2, pp. 120–121, 2004
79. Evidence-based medicine and ethics: a practical approach
    Journal of Medical Ethics, vol. 30, no. 2, pp. 126–130, 2004
80. A self-fulfilling prophecy: are we underestimating the role of the environment in gene-environment interaction research?
    International Journal of Epidemiology, vol. 33, no. 5, pp. 945–946, 2004
81. Individual susceptibility to carcinogens
    Oncogene, vol. 23, no. 38, Article ID 1207897, 6 pages, 2004
82. CYP1A1, GSTM1 and GSTT1 polymorphisms and lung cancer: a pooled analysis of gene-gene interactions
    Biomarkers, vol. 9, no. 3, pp. 298–305, 2004
83. Randomized controlled trial of dietary intervention: association between level of urinary phenolics and anti-mutagenicity
    Mutation Research/Genetic Toxicology and Environmental Mutagenesis, vol. 561, no. 1-2, pp. 83–90, 2004
84. Fruits and vegetables and prostate cancer: No association among 1,104 cases in a prospective study of 130,544 men in the European Prospective Investigation into Cancer and Nutrition (EPIC)
    International Journal of Cancer, vol. 109, no. 1, pp. 119–124, 2004
85. Association of metabolic gene polymorphisms with tobacco consumption in healthy controls
    International Journal of Cancer, vol. 110, no. 2, pp. 266–270, 2004
86. Outdoor air pollution and lung cancer: Recent epidemiologic evidence
    International Journal of Cancer, vol. 111, no. 5, pp. 647–652, 2004
87. Amount of DNA in plasma and cancer risk: A prospective study
    International Journal of Cancer, vol. 111, no. 5, pp. 746–749, 2004
88. CYP1A1 T3801 C polymorphism and lung cancer: A pooled analysis of 2,451 cases and 3,358 controls
    International Journal of Cancer, vol. 104, no. 5, pp. 650–657, 2003
89. Smoking and the risk of gastric cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC)
    International Journal of Cancer, vol. 107, no. 4, pp. 629–634, 2003
90. Dose-response relationship in tobacco-related cancers of bladder and lung: A biochemical interpretation
    International Journal of Cancer, vol. 108, no. 1, pp. 2–7, 2003
91. Fruits and vegetables and lung cancer: Findings from the European prospective investigation into cancer and nutrition
    International Journal of Cancer, vol. 108, no. 2, pp. 269–276, 2003
92. Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study
    The Lancet, vol. 361, no. 9368, pp. 1496–1501, 2003
93. Occupation and bladder cancer among men in Western Europe
    Cancer Causes & Control, vol. 14, no. 10, pp. 907–914, 2003
94. Delayed infection, late tonsillectomy or adenoidectomy and adult leukaemia: a case–control study
    British Journal of Cancer, vol. 88, no. 1, Article ID 6600689, 2 pages, 2003
95. Cancer as an evolutionary process at the cell level: an epidemiological perspective
    Carcinogenesis, vol. 24, no. 1, pp. 1–6, 2003
96. Biomarkers of dietary intake of micronutrients modulate DNA adduct levels in healthy adults
    Carcinogenesis, vol. 24, no. 4, pp. 739–746, 2003
97. The effects of diet on DNA bulky adduct levels are strongly modified by GSTM1 genotype: a study on 634 subjects
    Carcinogenesis, vol. 25, no. 4, pp. 577–584, 2003
98. Ras gene mutations in patients with acute myeloid leukaemia and exposure to chemical agents
    Carcinogenesis, vol. 25, no. 5, pp. 749–755, 2003
99. An evolutionary paradigm for carcinogenesis?
    Journal of Epidemiology & Community Health, vol. 57, no. 2, pp. 89–95, 2003
100. Determinants of 4-aminobiphenyl-DNA adducts in bladder cancer biopsies
     Carcinogenesis, vol. 23, no. 5, pp. 861–866, 2002
101. Health Care Analysis, vol. 10, no. 3, pp. 243–259, 2002
102. Pooled Analysis and Meta-analysis of Glutathione S-Transferase M1 and Bladder Cancer: A HuGE Review
     American Journal of Epidemiology, vol. 156, no. 2, pp. 95–109, 2002
103. The relationship between polymorphisms of xenobiotic metabolizing enzymes and susceptibility to cancer
     Toxicology, vol. 181-182, pp. 457–462, 2002
104. The Number Needed to Treat is Value-Laden
     Journal of Clinical Epidemiology, vol. 55, no. 1, pp. 102–103, 2002
105. DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-control study
     International Journal of Cancer, vol. 92, no. 4, pp. 562–567, 2001
106. Response toDNA adducts as a marker of cancer risk?
     International Journal of Cancer, vol. 92, no. 6, pp. 926–926, 2001
107. Cancer Causes and Control, vol. 12, no. 5, pp. 411–417, 2001
108. Cancer Causes and Control, vol. 12, no. 4, pp. 325–334, 2001
109. Misconceptions about the use of genetic tests in populations
     The Lancet, vol. 357, no. 9257, pp. 709–712, 2001
110. Inverse correlation between alcohol consumption and lymphocyte levels of 8-hydroxydeoxyguanosine in humans
     Carcinogenesis, vol. 22, no. 6, pp. 885–890, 2001
111. Lymphomas and Multiple Sclerosis in a Multicenter Case-Control Study
     Epidemiology, vol. 12, no. 1, pp. 134–135, 2001
112. Markers of DNA Repair and Susceptibility to Cancer in Humans: an Epidemiologic Review
     Journal of the National Cancer Institute, vol. 92, no. 11, pp. 874–897, 2000
113. Pharmacogenetics, vol. 10, no. 2, pp. 115–122, 2000
114. Delayed infection, family size and malignant lymphomas
     Journal of Epidemiology & Community Health, vol. 54, no. 12, pp. 907–911, 2000
115. Haematopoietic cancer and medical history: a multicentre case control study
     Journal of Epidemiology & Community Health, vol. 54, no. 6, pp. 431–436, 2000
116. Exposures, mutations and the history of causality
     Journal of Epidemiology & Community Health, vol. 54, no. 9, pp. 652–653, 2000
117. White blood cell DNA adducts and fruit and vegetable consumption in bladder cancer
     Carcinogenesis, vol. 21, no. 2, pp. 183–187, 2000
118. Cancer Causes and Control, vol. 11, no. 10, pp. 925–931, 2000
119. The choice of controls in a case–control study on WBC–DNA adducts and metabolic polymorphisms
     Biomarkers, vol. 5, no. 4, pp. 307–313, 2000
120. Cigarette smoking and bladder cancer in men: A pooled analysis of 11 case-control studies
     International Journal of Cancer, vol. 86, no. 2, pp. 289–294, 2000
121. Diet, metabolic polymorphisms and dna adducts: The epic-Italy cross-sectional study
     International Journal of Cancer, vol. 87, no. 3, pp. 444–451, 2000
122. DNA adducts as markers of exposure to carcinogens and risk of cancer
     International Journal of Cancer, vol. 88, no. 3, pp. 325–328, 2000
123. Annals of Oncology, vol. 11, no. 9, pp. 1201–1204, 2000
124. Discussion
     Mutation Research/Reviews in Mutation Research, vol. 463, no. 1, pp. 103–110, 2000
125. Impact of polymorphisms in xeno(endo)biotic metabolism on pattern and frequency of p53 mutations in bladder cancer
     Mutation Research/Reviews in Mutation Research, vol. 462, no. 2, pp. 303–309, 2000
126. Cancer Causes and Control, vol. 10, no. 3, pp. 209–217, 1999
127. Smoking as a confounder in case-control studies of occupational bladder cancer in women
     American Journal of Industrial Medicine, vol. 36, no. 1, pp. 75–82, 1999
128. Concordance between American Diabetes Association and World Health Organization criteria in a northwestern Italian population
     Diabetes Care, vol. 22, no. 4, pp. 652–653, 1999
129. 4-aminobiphenyl-DNA adducts and p53 mutations in bladder cancer
     International Journal of Cancer, vol. 75, no. 4, pp. 512–516, 1998
130. Biotherapy, vol. 11, no. 2/3, pp. 201–204, 1998
131. Antimutagenic dietary phenolics as antigenotoxic substances in urothelium of smokers
     Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 402, no. 1-2, pp. 219–224, 1998
132. Molecular epidemiology: Low-dose carcinogens and genetic susceptibility
     International Journal of Cancer, vol. 71, no. 1, pp. 1–3, 1997
133. Association of 1 hydroxypyrene glucuronide in human urine with cigarette smoking and broiled or roasted meat consumption
     Biomarkers, vol. 2, no. 4, pp. 217–221, 1997
134. Cancer Causes and Control, vol. 8, no. 3, pp. 346–355, 1997
135. Tobacco smoke, recurrences, and p53/bcl-2 expression in bladder cancer
     Carcinogenesis, vol. 18, no. 8, pp. 1659–1661, 1997
136. Ethical Issues in Genetic Screening and Genetic Monitoring of Employees
     Annals of the New York Academy of Sciences, vol. 837, no. 1, pp. 554–562, 1997
137. Genetic Testing: A Technology Assessment Perspective
     Annals of the New York Academy of Sciences, vol. 837, no. 1, pp. 566–569, 1997
138. Exposure to Aromatic Amines and ras and c-erbB-2 Overexpression in Bladder Cancer
     Journal of Occupational & Environmental Medicine, vol. 38, no. 4, pp. 390–393, 1996
139. Dietary phenolics as anti-mutagens and inhibitors of tobacco-related DNA adduction in the urothelium of smokers
     Carcinogenesis, vol. 17, no. 10, pp. 2193–2200, 1996
140. DNA adducts in urothelial cells: Relationship with biomarkers of exposure to arylamines and polycyclic aromatic hydrocarbons from tobacco smoke
     International Journal of Cancer, vol. 65, no. 3, pp. 314–316, 1996
141. Incidence rates of leukemias, lymphomas and myelomas in Italy: Geographic distribution and NHL histotypes
     International Journal of Cancer, vol. 68, no. 2, pp. 156–159, 1996
142. Interplay between heterocyclic amines in cooked meat and metabolic phenotype in the etiology of colon cancer
     Cancer Causes and Control, vol. 7, no. 4, pp. 479–486, 1996
143. Incidence and time trends for lymphomas, leukemias and myelomas: Hypothesis generation
     Leukemia Research, vol. 20, no. 4, pp. 285–290, 1996
144. Attributable risks and genetic predisposition
     Journal of Clinical Epidemiology, vol. 49, no. 5, p. 599, 1996
145. Tobacco and cancer: an update
     Critical Reviews in Oncology/Hematology, vol. 18, no. 2, pp. 103–110, 1995
146. Use of biomarkers in epidemiology. The example of metabolic susceptibility to cancer
     Toxicology Letters, vol. 77, no. 1-3, pp. 163–168, 1995
147. Scientific and ethical aspects of genetic screening of workers for cancer risk: The case of the n-acetyltransferase phenotype
     Journal of Clinical Epidemiology, vol. 48, no. 2, pp. 189–197, 1995
148. Medicine, practice and guidelines: The uneasy juncture of science and art
     Journal of Clinical Epidemiology, vol. 48, no. 7, pp. 875–880, 1995
149. Carcinogen-DNA adducts in bladder biopsies and urothelial cells: a risk assessment exercise
     Cancer Letters, vol. 84, no. 1, pp. 93–97, 1994
150. Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens
     Nature, vol. 369, no. 6476, Article ID 369154a0, 2 pages, 1994
151. Cancer Risk Assessment and Management
     Journal of Occupational and Environmental Medicine, vol. 35, no. 9, pp. 902–908, 1993
152. Mechanisms of carcinogenesis: Chemical exposure and molecular changes
     European Journal of Cancer, vol. 29, no. 9, pp. 1344–1347, 1993
153. Myeloid leukemias and myelodysplastic syndromes: chemical exposure, histologic subtype and cytogenetics in a case-control study
     Cancer Genetics and Cytogenetics, vol. 68, no. 2, pp. 135–139, 1993
154. Black (air-cured) and blond (flue-cured) tobacco cancer risk IV: Molecular dosimetry studies implicate aromatic amines as bladder carcinogens
     European Journal of Cancer, vol. 29, no. 8, pp. 1199–1207, 1993
155. Soft-tissue sarcoma
     Cancer Causes and Control, vol. 3, no. 5, pp. 493–494, 1992
156. Inter-observer and intra-observer variability of mammogram interpretation: a field study
     European Journal of Cancer, vol. 28, no. 6-7, pp. 1054–1058, 1992
157. The Role of Occupational Exposure and Immunodeficiency in B-Cell Malignancies
     Epidemiology, vol. 3, no. 3, pp. 266–270, 1992
158. Validation of a Method for the Estimation of Food Portion Size
     Epidemiology, vol. 3, no. 4, pp. 379–382, 1992
159. Relevance of metabolic polymorphisms to human carcinogenesis: evaluation of epidemiologic evidence
     Pharmacogenetics, vol. 1, no. 1, pp. 4–19, 1991
160. Causality assessment in epidemiology
     Theoretical Medicine, vol. 12, no. 2, pp. 171–181, 1991
161. The analysis of restriction fragment length polymorphism in human cancer: A review from an epidemiological perspective
     International Journal of Cancer, vol. 47, no. 1, pp. 26–30, 1991
162. Occupation and lung cancer in two industrialized areas of northern Italy
     International Journal of Cancer, vol. 41, no. 3, pp. 354–358, 1988
163. Coffee drinking and bladder cancer
     Cancer Letters, vol. 41, no. 1, pp. 45–52, 1988
164. Hemoglobin Adducts of Aromatic Amines: Associations with Smoking Status and Type of Tobacco
     Proceedings of the National Academy of Sciences, vol. 85, no. 24, pp. 9788–9791, 1988
165. Cigarette smoking and bladder cancer in females
     Cancer Letters, vol. 26, no. 1, pp. 61–66, 1985
166. Occupation and bladder cancer in males: A case-control study
     International Journal of Cancer, vol. 35, no. 5, pp. 599–606, 1985
167. Bladder cancer and smoking in males: Types of cigarettes, age at start, effect of stopping and interaction with occupation
     International Journal of Cancer, vol. 34, no. 2, pp. 165–170, 1984
168. Evidence of a multiplicative effect between c